Huang Lan, Peng Bo, Nayak Yash, Wang Cindy, Si Fusheng, Liu Xia, Dou Jie, Xu Huaxi, Peng Guangyong
Department of Immunology, School of Medicine, Jiangsu University, Zhenjiang, China.
Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, School of Medicine, Saint Louis University, St. Louis, MO, United States.
Front Cell Dev Biol. 2020 Aug 25;8:836. doi: 10.3389/fcell.2020.00836. eCollection 2020.
Malignant melanoma is one of the most common and dangerous skin cancers with a high rate of death every year. Furthermore, N-RAS and B-RAF mutations in melanoma cells increase the difficulties for clinical treatment in patients. Therefore, development of effective and universal drugs against melanoma is urgently needed. Here we demonstrate that baicalein and baicalin, the active components of the Chinese traditional medicinal plant Georgi, can significantly inhibit melanoma cell growth and proliferation, suppress tumor cell colony formation and migration, as well as induce apoptosis and senescence in melanoma cells. The anti-tumor effects mediated by baicalein and baicalin are independent of N-RAS and B-RAF mutation statuses in melanoma cells. Mechanistically, we identify that the suppression of baicalein and baicalin on melanoma cells is due to inhibition of tumor cell glucose uptake and metabolism by affecting the mTOR-HIF-1α signaling pathway. In addition, we demonstrated that baicalein and baicalin can suppress tumorigenesis and tumor growth in the melanoma model. These studies clearly indicate that baicalein and baicalin can control tumor growth and development metabolically and have great potential as novel and universal drugs for melanoma therapy.
恶性黑色素瘤是最常见且危险的皮肤癌之一,每年死亡率很高。此外,黑色素瘤细胞中的N-RAS和B-RAF突变增加了患者临床治疗的难度。因此,迫切需要开发有效的通用抗黑色素瘤药物。在此我们证明,中国传统药用植物黄芩中的活性成分黄芩素和黄芩苷可显著抑制黑色素瘤细胞的生长和增殖,抑制肿瘤细胞集落形成和迁移,并诱导黑色素瘤细胞凋亡和衰老。黄芩素和黄芩苷介导的抗肿瘤作用与黑色素瘤细胞中的N-RAS和B-RAF突变状态无关。从机制上讲,我们发现黄芩素和黄芩苷对黑色素瘤细胞的抑制作用是由于通过影响mTOR-HIF-1α信号通路抑制肿瘤细胞葡萄糖摄取和代谢。此外,我们证明黄芩素和黄芩苷可抑制黑色素瘤模型中的肿瘤发生和肿瘤生长。这些研究清楚地表明,黄芩素和黄芩苷可通过代谢控制肿瘤生长和发展,作为新型通用抗黑色素瘤治疗药物具有巨大潜力。